The
Way Forward for ME - A Case for Clinical Trials
The theme for conference number 6 focuses on the need for clinical trials for ME and
translational biomedical research.
Clinical trials are biomedical research studies which aim at determining the
efficacy, safety levels, and possible side-effects of new medications and
therapies. The majority of clinical trials involve the testing of new
medications designed to treat different conditions, ranging from auto-immune
and blood diseases to cancer. In the case of new medications, the trials are
normally jointly run by pharmaceutical companies, which are responsible for
designing the new drugs, and hospitals or health centres, which administer
them to patients.
We hope the conference will help further assist in shifting
the momentum toward biomedical research. Look out for more news
of the conference at
IIMEC6 News and in our newsletters.
Mrs Annette Whittemore,
President of the Whittemore-Peterson Institute, will be opening the
conference. It is appropriate that an organisation that has its roots in
helping patients, and which is furthering the idea of biomedical
translational research, should open the conference.
